Anulex Technologies
Founded Year
2001Stage
Dead | DeadTotal Raised
$74.5MAbout Anulex Technologies
Anulex Technologies, Inc. is a privately held company dedicated to the development and commercialization of soft tissue repair products with primary interests in treatments for the soft tissues of the spine. Anulex is located in Minnetonka, Minnesota.
Anulex Technologies Headquarter Location
5600 Rowland Road Suite 280
Minnetonka, Minnesota, 55343,
United States
952-224-4000
Anulex Technologies Patents
Anulex Technologies has filed 29 patents.
Application Date | Grant Date | Title | Related Topics | Status |
|---|---|---|---|---|
8/10/2010 | 2/18/2014 | Bones of the vertebral column, Ligaments of the torso, Spinal nerves, Medical equipment, Joints | Grant |
Application Date | 8/10/2010 |
|---|---|
Grant Date | 2/18/2014 |
Title | |
Related Topics | Bones of the vertebral column, Ligaments of the torso, Spinal nerves, Medical equipment, Joints |
Status | Grant |
Latest Anulex Technologies News
Jun 10, 2014
June 10, 2014 by Brad Perriello A federal judge dismisses Anulex from a lawsuit accusing it of promoting the off-label use of its Xclose tissue repair device. A federal judge last week dismissed Anulex Technologies from a lawsuit alleging unfair & deceptive trade practices for alleged off-label promotion of its Xclose soft tissue repair device. Bennie Evans sued Anulex, his back surgeon and the doctor's medical practice in 2010, alleging claims of negligent misrepresentation, fraud, unfair and deceptive trade practices, and breach of implied warranty. Sign up to get our free newsletters delivered straight to your inbox But Judge Terence Boyle, of the U.S. District Court for Eastern North Carolina, ruled that the sole claim against Anulex for unfair & deceptive trade practices is preempted by federal medical device law, according to court documents. "In his amended complaint, plaintiff alleges that Anulex conspired with physicians to use X-close sutures in annular repairs where patients had excellent prognoses for recovery in order to "stockpile" positive outcome cases so that it might gain FDA approval for use of X-close devices in annular repairs. At bottom, plaintiff seeks to hold Anulex liable for off-label promotion of its X-close suture device, but such claim is impliedly preempted as it exists solely by virtue of the requirements of the [Food, Drug & Cosmetic Act]," Boyle wrote in his June 4 ruling. Similar entries
When was Anulex Technologies founded?
Anulex Technologies was founded in 2001.
Where is Anulex Technologies's headquarters?
Anulex Technologies's headquarters is located at 5600 Rowland Road, Minnetonka.
What is Anulex Technologies's latest funding round?
Anulex Technologies's latest funding round is Dead.
How much did Anulex Technologies raise?
Anulex Technologies raised a total of $74.5M.
Who are Anulex Technologies's competitors?
Competitors of Anulex Technologies include PartsSource, MedShape, Intrinsic Therapeutics, SynergEyes, BioSet and 9 more.
You May Also Like
Serica is a medical device company focused on the development of silk-based biomaterial platforms that may be used in tissue repair. The company's approach leverages natural silk in combination with advances in biomedical engineering to address needs in the repair of damaged connective tissue, caused by disease, trauma, or aging. Serica's products are being studied for use in orthopaedics and sports medicine, aesthetic and reconstructive plastic surgery, and multiple additional structural tissue repair applications.
Biomimedica is developing earlier intervention solutions to treat osteoarthritis that will allow patients to maintain a pain-free, active lifestyle.
Intrinsic Therapeutics is a medical device company focused on delivering a safe treatment to improve outcomes in patients who are at a disproportionately high risk of requiring repeat surgeries due to reherniation following lumbar discectomy surgery.
Healionics develops and manufactures STAR Biomaterials for implanted medical devices. The precisely controlled pore structure of the STAR technology induces an integrated healing response, overcoming fibrotic reactions and infection issues to enhance medical device performance and longevity.
Biopharmaceutical products for the of spinal cord injuries and other central nervous system disorders.
OrthoMimetics aiming to bring to market a line of products for the regenerative repair of cartilage, ligament and tendon injuries.
Discover the right solution for your team
The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.